Radiation Oncology

Prof. Dr. Gül Alço

Doctor and researcher MEDİPOL Acıbadem Bölge Hastanesi İstanbul
Breast NeoplasmsProstatic NeoplasmsBreast Cancer LymphedemaUterine Cervical Neoplasms

Is this your profile? Claim it and verify your details.

Claim profile

The CV on this page was translated automatically from its original language. See the original

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 19 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Prostatic Neoplasms 4 publications
  • Breast Cancer Lymphedema 2 publications
  • Uterine Cervical Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medipol.com.tr.

  • Breast cancer
  • Lung cancer
  • Prostate cancer
  • Gastrointestinal cancers
  • Gynaecological cancers
  • Central nervous system tumours
  • Head and neck tumours
  • Soft tissue and bone tumours
  • Adaptive radiotherapy
  • Radiosurgery

CV

Education and experience

From source

Education

  • 2003Kadir Has University Faculty of Medicine, Radiation Oncologymedipol.com.tr
  • 1995Istanbul University, Faculty of Medicinemedipol.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyRadiation Oncologymedipol.com.trFrom source
  • Department name at the sourceRadyasyon Onkolojimedipol.com.trFrom source
  • InstitutionMEDİPOL Acıbadem Bölge Hastanesimedipol.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 19 publications · Model version —From source
  • Publications222 publicationsOpenAlexFrom source
  • LanguagesEnglishmedipol.com.trFrom source
  • Last synchronised4 November 2026 20:15https://medipol.com.tr/doktorlarimiz/profdr-gul-alcomedipol.com.tr

Scientific work

Publications on Breast Neoplasms

222 publications
Publications by year Most: 11, in 2016
  1. 2007: 2 publications
  2. 2008: 2 publications
  3. 2009: 9 publications
  4. 2010: 5 publications
  5. 2011: 8 publications
  6. 2012: 3 publications
  7. 2013: 1 publication
  8. 2014: 10 publications
  9. 2015: 6 publications
  10. 2016: 11 publications
  11. 2017: 3 publications
  12. 2018: 5 publications
  13. 2019: 3 publications
  14. 2020: 4 publications
  15. 2021: 5 publications
  16. 2022: 4 publications
  17. 2023: 3 publications
  18. 2024: 3 publications
  19. 2025: 2 publications
  1. Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial

    World Journal of Surgery, 2025

    DOI 10.1002/wjs.12587 PMID 40229998 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance

    European Journal of Breast Health, 2025

    DOI 10.4274/ejbh.galenos.2024.2024-9-5 PMID 39744892 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Outcomes of reconstructive techniques in breast cancer using BCCT. core software

    World Journal of Surgical Oncology, 2024

    DOI 10.1186/s12957-024-03343-3 PMID 38519998 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  4. Gamma Knife radiosurgery for the treatment of trigeminal neuralgia: A single center-experience

    Neurocirugía (English Edition), 2024

    DOI 10.1016/j.neucie.2024.04.001 PMID 38642616 Source: OpenAlex

  5. The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy

    European Journal of Breast Health, 2024

    DOI 10.4274/ejbh.galenos.2024.2023-12-5 PMID 38571683 Open-access full textSource: OpenAlex

  6. Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey

    Frontiers in Oncology, 2023

    DOI 10.3389/fonc.2023.1151733 PMID 37448522 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study

    Current Oncology, 2023

    DOI 10.3390/curroncol30100666 PMID 37887566 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification

    Breast Cancer Targets and Therapy, 2023

    DOI 10.2147/bctt.s421535 PMID 37674872 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Deep inspiration breath hold in left sided tangential breast radiotherapy: Degree of lung inflation needed to compansate for cardiac motion

    Internatuinal Journal of Radiation Research, 2022

    DOI 10.52547/ijrr.20.2.11 Source: OpenAlex

  10. Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer

    Oncology Letters, 2022

    DOI 10.3892/ol.2022.13238 PMID 35261632 1 citation (Europe PMC) Open-access full textSource: OpenAlex

View all 222 publications